Cat. No. | Product Name / Activity |
---|---|
0500 | N1,N12-Diethylspermine tetrahydrochloride |
Polyamine synthase inhibitor | |
0504 | Diphenyleneiodonium chloride |
GPR3 agonist; also inhibits NOS and NADPH oxidases | |
0505 | Dihydroergotoxine mesylate |
Binds to GABAA receptor Cl- channel; allosteric modulator of benzodiazepine site | |
0506 | Dimaprit dihydrochloride |
Standard H2 selective agonist | |
0507 | Dantrolene, sodium salt |
Ca2+ release inhibitor | |
0512 | SKF 91488 dihydrochloride |
Histamine N-methyltransferase inhibitor | |
0513 | GBR 12783 dihydrochloride |
Potent and selective DA uptake inhibitor | |
0514 | GBR 12935 dihydrochloride |
Selective dopamine uptake inhibitor | |
0515 | Dobutamine hydrochloride |
α1, β1 and β2 agonist | |
0523 | 4F 4PP oxalate |
Selective 5-HT2A antagonist | |
0524 | AMI-193 |
D2-like antagonist; also selective 5-HT2 antagonist | |
0526 | (±)-Hexanoylcarnitine chloride |
Intermediate in lipid metabolism | |
0529 | 8-Hydroxy-DPAT hydrobromide |
Selective 5-HT1A agonist; also has moderate affinity for 5-HT7 | |
0532 | W-84 dibromide |
Stabilizer of cholinergic antagonist-receptor complexes | |
0535 | HEAT hydrochloride |
Highly selective α1 antagonist | |
0541 | Fasudil hydrochloride |
Inhibitor of cyclic nucleotide dependent- and Rho-kinases | |
0542 | H-7 dihydrochloride |
Protein kinase inhibitor | |
0543 | C-1 |
Inhibits PKG, PKA and PKC | |
0544 | IPAG |
Potent σ antagonist | |
0545 | Ifenprodil hemitartrate |
Non-competitive NMDA antagonist; also σ ligand | |
0546 | L-NIO dihydrochloride |
NOS inhibitor | |
0548 | (±)-Lauroylcarnitine chloride |
Intermediate in lipid metabolism | |
0549 | Methylergometrine maleate |
Active metabolite of methysergide (Cat. No. 1064) | |
0552 | MMPX |
PDE1 inhibitor | |
0553 | NAN-190 hydrobromide |
5-HT1A antagonist | |
0554 | FG 7142 |
Benzodiazepine inverse agonist | |
0556 | BP 554 maleate |
Selective 5-HT1A agonist | |
0566 | N-Methylquipazine dimaleate |
5-HT3 agonist | |
0567 | (±)-Myristoylcarnitine chloride |
Intermediate in lipid metabolism | |
0569 | (R)-(-)-α-Methylhistamine dihydrobromide |
Potent, standard H3 agonist | |
0571 | PCA 4248 |
PAF receptor antagonist | |
0573 | Nα-Methylhistamine dihydrochloride |
Non-selective H3 agonist | |
0577 | Methyl 2,5-dihydroxycinnamate |
EGFR-kinase inhibitor | |
0579 | Tyrphostin B44, (+) enantiomer |
EGFR-kinase inhibitor | |
0583 | Minoxidil |
Kir6 channel (KATP) opener | |
0584 | L-(-)-α-Methyldopa |
Aromatic L-amino acid decarboxylase inhibitor | |
0588 | 5-Methylfurmethiodide |
Potent muscarinic agonist | |
0589 | PRE-084 hydrochloride |
Highly selective σ1 agonist | |
0590 | Metergoline |
5-HT2 antagonist. Also 5-HT1 antagonist and 5-HT1D ligand. Has moderate affinity for 5-HT6 and high affinity for 5-HT7 | |
0591 | Naloxonazine dihydrochloride |
Selective μ1 antagonist | |
0593 | NPPB |
Inhibits calcium-sensitive chloride currents | |
0597 | Naftopidil hydrochloride |
α1 antagonist | |
0598 | SNAP |
A stable analog of endogenous S-nitroso compounds | |
0599 | Naloxone hydrochloride |
Non-selective opioid antagonist |